Nvidia-Backed Iambic Files for IPO Amidst AI-Focused Biotech Boom

Iambic Therapeutics, backed by Nvidia, has filed for an initial public offering (IPO), revealing new details about its clinic and dealmaking activities.

The San Diego-based company is one of the latest AI-focused biotech startups to mature. The IPO filing comes as Iambic's growth accelerates, with significant investments from major players like Nvidia.

Iambic co-founders Fred Manby and Tom Miller have been instrumental in driving innovation within the company. With this IPO, they aim to raise capital for further research and development of their AI technologies.

The company's clinic activities are also receiving attention, with details emerging about its operations. However, specific information is limited at this stage due to the confidential nature of business dealings.